ATE344230T1 - Triphenylbutenderivate zur behandlung von neurologischen störungen - Google Patents
Triphenylbutenderivate zur behandlung von neurologischen störungenInfo
- Publication number
- ATE344230T1 ATE344230T1 AT99954098T AT99954098T ATE344230T1 AT E344230 T1 ATE344230 T1 AT E344230T1 AT 99954098 T AT99954098 T AT 99954098T AT 99954098 T AT99954098 T AT 99954098T AT E344230 T1 ATE344230 T1 AT E344230T1
- Authority
- AT
- Austria
- Prior art keywords
- treatment
- neurological disorders
- triphenyl
- butene derivatives
- butene
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/222—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/223—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of alpha-aminoacids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
- A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Saccharide Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pyridine Compounds (AREA)
- Pyrrole Compounds (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9824207.6A GB9824207D0 (en) | 1998-11-04 | 1998-11-04 | Neurological disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE344230T1 true ATE344230T1 (de) | 2006-11-15 |
Family
ID=10841850
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT99954098T ATE344230T1 (de) | 1998-11-04 | 1999-10-29 | Triphenylbutenderivate zur behandlung von neurologischen störungen |
Country Status (9)
Country | Link |
---|---|
US (1) | US6489481B1 (de) |
EP (1) | EP1127045B1 (de) |
JP (1) | JP2002528489A (de) |
AT (1) | ATE344230T1 (de) |
AU (1) | AU1054200A (de) |
DE (1) | DE69933885T2 (de) |
ES (1) | ES2274645T3 (de) |
GB (1) | GB9824207D0 (de) |
WO (1) | WO2000025767A2 (de) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7710744B2 (en) * | 2004-10-11 | 2010-05-04 | Stmicroelectronics S.R.L. | Method for controlling a full bridge converter with a current-doubler |
WO2007076875A2 (en) * | 2006-01-06 | 2007-07-12 | Aarhus Universitet | Compounds acting on the serotonin transporter |
US8062588B2 (en) * | 2006-03-22 | 2011-11-22 | Zimek Technologies Ip, Llc | Ultrasonic sanitation device and associated methods |
JP5382633B2 (ja) * | 2006-05-25 | 2014-01-08 | 学校法人順正学園 | 脳血管性認知症の予防または治療薬 |
US20090291134A1 (en) * | 2006-11-21 | 2009-11-26 | Jina Pharmaceuticals, Inc. | Endoxifen methods and compositions in the treatment of psychiatric and neurodegenerative diseases |
JP7325104B2 (ja) * | 2016-07-27 | 2023-08-14 | ケース ウェスタン リザーブ ユニバーシティ | ミエリン形成を促進する化合物および方法 |
JP7282028B2 (ja) | 2017-06-02 | 2023-05-26 | 富士フイルム富山化学株式会社 | 脳萎縮予防または治療剤 |
CN110691593B (zh) | 2017-06-02 | 2023-05-02 | 富士胶片富山化学株式会社 | 脊髓小脑变性症预防或治疗剂 |
US11666551B2 (en) | 2017-06-02 | 2023-06-06 | Fujifilm Toyama Chemical Co., Ltd. | Agent for reducing amount of amyloid β protein |
EP3636262A4 (de) | 2017-06-02 | 2020-06-10 | FUJIFILM Toyama Chemical Co., Ltd. | Mittel zur prävention und/oder behandlung von demenz vom alzheimertyp |
CN109293519B (zh) * | 2017-07-25 | 2021-09-28 | 北京斯利安药业有限公司 | 一种枸橼酸他莫昔芬晶型a的制备方法 |
WO2019088083A1 (ja) * | 2017-10-30 | 2019-05-09 | 富士フイルム富山化学株式会社 | エモパミル結合タンパク質結合剤およびその利用 |
US11325883B2 (en) | 2017-11-22 | 2022-05-10 | Temple University—Of the Commonwealth System of Higher Education | Functionalized N,N-dialkylamino phenyl ethers and their method of use |
CN113365641A (zh) * | 2018-09-12 | 2021-09-07 | 路易斯安那泽维尔大学 | ***受体靶向拮抗剂 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE637389A (de) * | 1962-09-13 | |||
US3288806A (en) * | 1964-03-23 | 1966-11-29 | Parke Davis & Co | Alpha-(aminoethoxyphenyl)-alpha-alkylstilbenes |
DE2860900D1 (en) * | 1977-08-22 | 1981-11-05 | Ici Plc | Triphenylalkene derivatives, process for their preparation and pharmaceutical compositions containing them |
ATE2423T1 (de) * | 1978-11-07 | 1983-03-15 | Imperial Chemical Industries Plc | 1-acyloxyphenyl-1,2-diphenylalken-derivate, verfahren zu deren herstellung und eine diese derivate enthaltende pharmazeutische zusammensetzung. |
DE4311870C2 (de) * | 1993-04-10 | 1998-07-30 | Altramed Holdings Ltd | Verwendung eines Anti-Östrigens zur Therapie und Prophylaxe von Demenz-Erkrankungen |
DE4320896A1 (de) * | 1993-06-24 | 1995-01-05 | Denecke Rainer Dr Med Vet | Präparat zur Therapie und Prophylaxe von Demenz-Erkrankungen |
JPH11510479A (ja) * | 1995-06-07 | 1999-09-14 | ネオルックス コーポレイション | タモキシフェン類似体による心臓血管疾病の予防及び治療 |
IL120269A0 (en) * | 1996-02-28 | 1997-06-10 | Pfizer | 1,1,2-triphenylbut-1-ene derivatives for treating Alzheimer's disease |
AU7260398A (en) * | 1997-04-28 | 1998-11-24 | University Of British Columbia, The | Method and composition for modulating amyloidosis |
HUP0002852A3 (en) * | 1997-08-15 | 2001-11-28 | Univ Durham | A method of preventing or treating estrogen-dependent diseases and disorders using triphenil-ethylene derivatives |
EP0976404A3 (de) * | 1998-07-30 | 2001-06-27 | Pfizer Products Inc. | Pharmazeutische Zubereitung zur Vorbeugung und Behandlung von kognitiven Störungen bei Säugetieren |
-
1998
- 1998-11-04 GB GBGB9824207.6A patent/GB9824207D0/en not_active Ceased
-
1999
- 1999-10-29 EP EP99954098A patent/EP1127045B1/de not_active Expired - Lifetime
- 1999-10-29 DE DE69933885T patent/DE69933885T2/de not_active Expired - Fee Related
- 1999-10-29 ES ES99954098T patent/ES2274645T3/es not_active Expired - Lifetime
- 1999-10-29 AT AT99954098T patent/ATE344230T1/de not_active IP Right Cessation
- 1999-10-29 JP JP2000579208A patent/JP2002528489A/ja active Pending
- 1999-10-29 WO PCT/GB1999/003583 patent/WO2000025767A2/en active IP Right Grant
- 1999-10-29 US US09/831,211 patent/US6489481B1/en not_active Expired - Fee Related
- 1999-10-29 AU AU10542/00A patent/AU1054200A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU1054200A (en) | 2000-05-22 |
EP1127045B1 (de) | 2006-11-02 |
EP1127045A2 (de) | 2001-08-29 |
DE69933885D1 (de) | 2006-12-14 |
ES2274645T3 (es) | 2007-05-16 |
WO2000025767A3 (en) | 2000-09-28 |
US6489481B1 (en) | 2002-12-03 |
DE69933885T2 (de) | 2007-05-24 |
WO2000025767A2 (en) | 2000-05-11 |
JP2002528489A (ja) | 2002-09-03 |
GB9824207D0 (en) | 1998-12-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2191048T3 (es) | Derivados de oxazolidinona y compuestos farmaceuticos que los contienen. | |
DE60112609D1 (en) | Pyrazolopyridine | |
ATE296826T1 (de) | Pyrazolo(1,5)pyridinderivate | |
ATE337316T1 (de) | Imidazo 1,2-aöpyridin-derivate zur prophylaxe und behandlung von herpes-infektionen | |
BR0108893B1 (pt) | composiÇço farmacÊutica contendo derivados de azetidina, composto derivado de azetidina, e, processo para a preparaÇço de compostos. | |
BG104998A (en) | Isothiazole derivatives useful as anticancer agents | |
MXPA04001016A (es) | Derivados de sulfonamida como inhibidores de la gamma secretasa. | |
ES2243579T3 (es) | Derivados de pirazolopirideno. | |
EA200500174A1 (ru) | Новые производные бензимидазола, полезные в качестве антипролиферативных агентов | |
YU95102A (sh) | Supstituisani biciklični derivati u lečenju abnormalnog rasta ćelija | |
RU2088589C1 (en) | Derivatives of 17 beta-substituted-4-aza-5-5 alpha-androstane-3-ones, methods of synthesis of compounds, pharmaceutical composition, compound 4 | |
DK1029853T3 (da) | Heteroaromatiske bicykliske derivativer, der er egnede som anticancermidler | |
SE9903760D0 (sv) | New compounds | |
HRP20050390A2 (en) | Substituted benzoxazinones and uses thereof | |
ATE344230T1 (de) | Triphenylbutenderivate zur behandlung von neurologischen störungen | |
WO1999020606A3 (en) | Piperidines and piperazines as platelet aggregation inhibitors | |
NO20003018L (no) | Triazinangiogenese-inhibitorer | |
ES2168304T3 (es) | Derivados del taxol. | |
RU94036745A (ru) | Производные галантамина и фармацевтическая композиция | |
EE200000472A (et) | Kasvajavastased toimeained | |
MY138466A (en) | Aminoalkoxyndoles as 5-ht6-receptor ligands for the treatment of cns-disorders | |
ATE297904T1 (de) | Halo-alkoxycarbonylverbindungen | |
DE69410614T2 (de) | Bis-naphthalimide für die behandlung von krebs | |
MXPA05010783A (es) | Derivados antimicrobianos de [3.1.0] biciclohexilfenil-oxazolidinona y analogos. | |
ATE274515T1 (de) | Pyrazolopyridinderivate |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |